Delivery Order SPE2DR25D2006-SPE2DR26F57GP
- Not listed
- The Defense Logistics Agency awarded a $7,623.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsules (6-count units) on December 12, 2025, with completion scheduled for December 15, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,792.44 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules (6-count units) under a firm fixed price contract. This non-set-aside award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.27 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5 count). The contract, executed on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsule unit dose 5-count packages, valued at $10,666.78 with a firm fixed price structure. The contract, awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a non-competitive set-aside delivery order executed through AmerisourceBergen's existing indefinite delivery contract vehicle. The point of performance is located in...
- The Defense Logistics Agency awarded a $1,857.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsules (unit dose, 2 count packaging) on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,247.16 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (quantity 6). This non-set-aside, firm fixed price delivery order was awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order operates under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on January 5, 2026, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5 units. This is a firm fixed-price delivery order valued at $6,492.22, with an ultimate completion date of January 6, 2026. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,836.80 to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsule unit dose packages (six-count) on November 3, 2025, with completion expected by November 4, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.13 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This firm fixed price, non-set-aside contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV) prevention medication commonly utilized in...
- The Defense Logistics Agency awarded a delivery order valued at $11,086.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit dose packaging (six-count). This order was competitively awarded without set-aside designation and carries a firm fixed price contract type, with an ultimate completion date of November 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57GPDelivery Order
The Defense Logistics Agency awarded a $2,899.88 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Aprepitant 125 mg capsules in unit dose packaging (6-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 13, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen operates as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities. The parent Indefinite Delivery Contract encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Aprepitant, an antiemetic medication commonly used in cancer treatment protocols, represents routine fulfillment under this strategic contract vehicle designed to ensure reliable access to essential pharmaceuticals across military healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/11/26 |